Literature DB >> 27644131

Hiding in the Shadows: CPOX Expression and 5-ALA Induced Fluorescence in Human Glioma Cells.

Nikolay Pustogarov1,2, Dmitriy Panteleev1, Sergey A Goryaynov3, Anastasia V Ryabova4, Ekaterina Y Rybalkina5, Alexander Revishchin1,2, Alexander A Potapov3, Galina Pavlova6,7.   

Abstract

Protoporphyrin IX (PpIX) is widely used in photodynamic diagnosis. To date, the details of molecular mechanisms underlying PpIX accumulation in malignant cells after 5-ALA administration remain unclear. The fluorescence of PpIX was studied in human glioma cells. Several cell cultures were established from glioma tumor tissue to study the differences between fluorescence-positive and fluorescence-negative human glioma tumors. The cell cultures demonstrated fluorescence profiles similar to those of source tumor tissues, which allows us to use these cultures in experimental research. Dynamics of the rates of synthesis and degradation of fluorescent protoporphyrin IX was studied in the cultures obtained. In addition, the expression of CPOX, an enzyme involved in PpIX synthesis, was evaluated. mRNA levels of heme biosynthesis enzymes were analyzed, and PpIX fluorescence proved to correlate with the CPOX protein level, whereas no such correlation was observed at the mRNA level. Fluorescence intensity decreased at low levels of the enzyme, which indicates its critical role in PpIX fluorescence. Finally, the fluorescence intensity proved to correlate with the proliferative activity.

Entities:  

Keywords:  5-ALA; CPOX; Cell cultures; Glioma; PpIX

Mesh:

Substances:

Year:  2016        PMID: 27644131     DOI: 10.1007/s12035-016-0109-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  26 in total

1.  Transport of 5-aminolevulinic acid between blood and brain.

Authors:  S R Ennis; A Novotny; J Xiang; P Shakui; T Masada; W Stummer; D E Smith; R F Keep
Journal:  Brain Res       Date:  2003-01-10       Impact factor: 3.252

Review 2.  Promising nucleic acid analogs and mimics: characteristic features and applications of PNA, LNA, and morpholino.

Authors:  Shantanu Karkare; Deepak Bhatnagar
Journal:  Appl Microbiol Biotechnol       Date:  2006-05-09       Impact factor: 4.813

3.  Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence.

Authors:  W Stummer; S Stocker; S Wagner; H Stepp; C Fritsch; C Goetz; A E Goetz; R Kiefmann; H J Reulen
Journal:  Neurosurgery       Date:  1998-03       Impact factor: 4.654

Review 4.  5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.

Authors:  Q Peng; T Warloe; K Berg; J Moan; M Kongshaug; K E Giercksky; J M Nesland
Journal:  Cancer       Date:  1997-06-15       Impact factor: 6.860

5.  Radiation response and survival time in patients with glioblastoma multiforme.

Authors:  F G Barker; M D Prados; S M Chang; P H Gutin; K R Lamborn; D A Larson; M K Malec; M W McDermott; P K Sneed; W M Wara; C B Wilson
Journal:  J Neurosurg       Date:  1996-03       Impact factor: 5.115

6.  Is delta-aminolevulinic acid dehydratase rate limiting in heme biosynthesis following exposure of cells to delta-aminolevulinic acid?

Authors:  S L Gibson; J J Havens; L Metz; R Hilf
Journal:  Photochem Photobiol       Date:  2001-03       Impact factor: 3.421

7.  The long, but not the short, presequence of human coproporphyrinogen oxidase is essential for its import and sorting to mitochondria.

Authors:  Shinji Susa; Makoto Daimon; Hideyu Ono; Song Li; Tadashi Yoshida; Takeo Kato
Journal:  Tohoku J Exp Med       Date:  2003-05       Impact factor: 1.848

8.  Low-dose arsenic trioxide enhances 5-aminolevulinic acid-induced PpIX accumulation and efficacy of photodynamic therapy in human glioma.

Authors:  Chunlei Wang; Xiaofeng Chen; Jianing Wu; Huailei Liu; Zhiyong Ji; Huaizhang Shi; Cheng Gao; Dayong Han; Ligang Wang; Yaohua Liu; Guang Yang; Changyu Fu; Huadong Li; Dongzhi Zhang; Ziyi Liu; Xianfeng Li; Fei Yin; Shiguang Zhao
Journal:  J Photochem Photobiol B       Date:  2013-06-26       Impact factor: 6.252

9.  Protoporphyrin IX binding and transport by recombinant mouse PBR.

Authors:  Gregor Wendler; Peter Lindemann; Jean-Jacques Lacapère; Vassilios Papadopoulos
Journal:  Biochem Biophys Res Commun       Date:  2003-11-28       Impact factor: 3.575

Review 10.  Heterogeneity and cancer.

Authors:  Kimberly H Allison; George W Sledge
Journal:  Oncology (Williston Park)       Date:  2014-09       Impact factor: 2.990

View more
  9 in total

1.  Capability of physically reasonable OCT-based differentiation between intact brain tissues, human brain gliomas of different WHO grades, and glioma model 101.8 from rats.

Authors:  I N Dolganova; P V Aleksandrova; P V Nikitin; A I Alekseeva; N V Chernomyrdin; G R Musina; S T Beshplav; I V Reshetov; A A Potapov; V N Kurlov; V V Tuchin; K I Zaytsev
Journal:  Biomed Opt Express       Date:  2020-10-28       Impact factor: 3.732

2.  Heme Biosynthesis Factors and 5-ALA Induced Fluorescence: Analysis of mRNA and Protein Expression in Fluorescing and Non-fluorescing Gliomas.

Authors:  Mario Mischkulnig; Thomas Roetzer-Pejrimovsky; Daniela Lötsch-Gojo; Nina Kastner; Katharina Bruckner; Romana Prihoda; Alexandra Lang; Mauricio Martinez-Moreno; Julia Furtner; Anna Berghoff; Adelheid Woehrer; Walter Berger; Georg Widhalm; Barbara Kiesel
Journal:  Front Med (Lausanne)       Date:  2022-05-18

3.  Terahertz spectroscopy of gelatin-embedded human brain gliomas of different grades: a road toward intraoperative THz diagnosis.

Authors:  Arseniy A Gavdush; Nikita V Chernomyrdin; Kirill M Malakhov; Sheyh-Islyam T Beshplav; Irina N Dolganova; Alexandra V Kosyrkova; Pavel V Nikitin; Guzel R Musina; Gleb M Katyba; Igor V Reshetov; Olga P Cherkasova; Gennady A Komandin; Valery E Karasik; Alexander A Potapov; Valery V Tuchin; Kirill I Zaytsev
Journal:  J Biomed Opt       Date:  2019-02       Impact factor: 3.170

4.  TCGA mRNA Expression Analysis of the Heme Biosynthesis Pathway in Diffusely Infiltrating Gliomas: A Comparison of Typically 5-ALA Fluorescent and Non-Fluorescent Gliomas.

Authors:  Mario Mischkulnig; Barbara Kiesel; Daniela Lötsch; Thomas Roetzer; Martin Borkovec; Lisa I Wadiura; Petra A Mercea; Florian J Jaklin; Shawn Hervey-Jumper; Karl Roessler; Mitchel S Berger; Georg Widhalm; Friedrich Erhart
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.639

Review 5.  Molecular and Metabolic Mechanisms Underlying Selective 5-Aminolevulinic Acid-Induced Fluorescence in Gliomas.

Authors:  Jeffrey I Traylor; Mark N Pernik; Alex C Sternisha; Samuel K McBrayer; Kalil G Abdullah
Journal:  Cancers (Basel)       Date:  2021-02-02       Impact factor: 6.639

6.  The impact of heme biosynthesis regulation on glioma aggressiveness: Correlations with diagnostic molecular markers.

Authors:  Mario Mischkulnig; Barbara Kiesel; Thomas Rötzer-Pejrimovsky; Martin Borkovec; Alexandra Lang; Matthias Millesi; Lisa I Wadiura; Shawn Hervey-Jumper; Josef M Penninger; Mitchel S Berger; Georg Widhalm; Friedrich Erhart
Journal:  Front Mol Neurosci       Date:  2022-09-14       Impact factor: 6.261

7.  Mapping and Quantification of Non-Coding RNA Originating from the rDNA in Human Glioma Cells.

Authors:  Anastasia A Sadova; Natalia S Kupriyanova; Galina V Pavlova
Journal:  Cancers (Basel)       Date:  2020-07-28       Impact factor: 6.639

Review 8.  Role of Bcl-2 Family Proteins in Photodynamic Therapy Mediated Cell Survival and Regulation.

Authors:  Eric Chekwube Aniogo; Blassan Plackal Adimuriyil George; Heidi Abrahamse
Journal:  Molecules       Date:  2020-11-13       Impact factor: 4.411

9.  5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized Centers.

Authors:  Arthur Hosmann; Matthias Millesi; Lisa I Wadiura; Barbara Kiesel; Petra A Mercea; Mario Mischkulnig; Martin Borkovec; Julia Furtner; Thomas Roetzer; Stefan Wolfsberger; Joanna J Phillips; Anna S Berghoff; Shawn Hervey-Jumper; Mitchel S Berger; Georg Widhalm
Journal:  Cancers (Basel)       Date:  2021-05-21       Impact factor: 6.575

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.